Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02929212
Other study ID # AAAO3051
Secondary ID R01DK067561
Status Completed
Phase N/A
First received October 7, 2016
Last updated January 30, 2017
Start date September 2009
Est. completion date April 2014

Study information

Verified date January 2017
Source Columbia University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine the effect of meal size and texture on the levels of incretin hormone, GLP-1, after Gastric Bypass Surgery (GBP). Patterns of food intake change after bariatric surgery and patients often eat multiple small low-calorie meals, a pattern that may affect blood glucose as well as incretin levels. Whether the release of GLP-1 after an oral challenge or a single liquid meal has any physiological relevance in 'real life' setting of multiple small meals diet is unclear.


Description:

The main goal is to study the effect of meal size and texture on incretin levels after GBP. Patients will be studied before GBP (T0) and 12-15 months after GBP (T1). At T0 and T1, patients will come for 2 study days for 8 hours: On one study day, a single meal will be served, on the second study day, three small meals, with the order of the conditions randomly assigned. The total amount of calories (600 kcal) and the over all nutrient composition (55% CHO, 15 % protein, 30% fat) will be equivalent between conditions. The meals will be either all solid or all liquid. Patients enrolled in the study will be randomly assigned to solid or liquid test meals.

Recruitment and data gathering for this study were performed at St. Luke's Hospital in New York, NY. Data Analysis was performed at Columbia University Medical Center in New York, NY.


Recruitment information / eligibility

Status Completed
Enrollment 33
Est. completion date April 2014
Est. primary completion date April 2014
Accepts healthy volunteers No
Gender All
Age group 21 Years to 60 Years
Eligibility Inclusion Criteria: morbidly obese individuals, BMI above 35 and less than 50 kg/m2 who chose GBP as treatment for their obesity

- Must be able to attend all study visits at St. Luke's Roosevelt Hospital Center in Manhattan, New York City

- Individuals with or without Type 2 Diabetes Mellitus are eligible

Exclusion Criteria:

- Patients with abnormal thyroid, renal function, known malabsorption syndrome or a seizure disorder requiring anti epileptic therapy, and/or elevation of liver enzymes three times above the normal limit.

- Patients with intestinal conditions such as chronic diarrhea, diverticulitis, or irritable bowel syndrome.

- Currently pregnant or nursing.

- Known cardiovascular disease.

- Patient with current mucosal (gastrointestinal, respiratory, urogenital) or skin (cellulitis) infection

- Any other condition which, in the opinion of the investigators, may make the candidate unsuitable for participation in this study.

- past history of severe food allergy

- History of Type 1 Diabetes Mellitus

- Individuals taking insulin, thiazolidinedione, exenatide, or DPP-IV inhibitors

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Solid Meal
Subjects will receive solid meals during meal study
Liquid Meal
Subjects will receive liquid meals, during meal study
Drug:
Acetaminophen
All subjects given acetaminophen to measure gastric emptying
Other:
Single, 600 kcal meal
Subjects will receive a single, 600 kcal meal during meal study
Multiple, 200 kcal meals
Subjects will receive three, 200 kcal meals, during meal study

Locations

Country Name City State
United States New York Obesity Nutrition Research Center, St. Luke's-Roosevelt Hospital Center New York New York

Sponsors (2)

Lead Sponsor Collaborator
Columbia University National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Difference in GLP-1 levels before and after gastric bypass surgery Investigators will assess GLP-1 levels in subjects pre and post-GBP 12-15 months
Primary Difference in glucose levels before and after gastric bypass surgery Investigators will assess glucose in subjects pre and post-GBP 12-15 months
Primary Difference in insulin levels before and after gastric bypass surgery Investigators will assess insulin levels in subjects pre and post-GBP 12-15 months
Secondary Difference in GLP-1 levels in solid vs liquid meals Investigators will assess GLP-1 levels in subjects eating either liquid or solid meals at both pre-surgery and post-surgery time points 12-15 months
Secondary Difference in glucose levels in solid vs liquid meals Investigators will assess glucose levels in subjects eating either liquid or solid meals at both pre-surgery and post-surgery time points 12-15 months
Secondary Difference in insulin levels in solid vs liquid meals Investigators will assess insulin levels in subjects eating either liquid or solid meals at both pre-surgery and post-surgery time points 12-15 months
See also
  Status Clinical Trial Phase
Completed NCT03657927 - A Comparison of McGrath MAC Versus C-MAC Videolaryngoscopes in Morbidly Obese Patients N/A
Recruiting NCT04934826 - Comparison of the Absorption of Hydrolyzed or Intact Proteins in Morbid Obese Patients After the Roux Y Gastric Bypass N/A
Completed NCT03181347 - The Microbiology of Bariatric Surgery N/A
Completed NCT03886870 - Obesity, Lifestyle and Work Intervention N/A
Active, not recruiting NCT04433338 - The PREBA Study: Effect of Preoperative Weight Loss With a 14-day Low-calorie Diet on Surgical Procedure and Outcomes in Patients Undergoing RYGB Surgery N/A
Completed NCT03553849 - Utilization of Very Low Calorie Diet in Obese General Surgery Patients N/A
Completed NCT05854875 - Diabetes Remission After RYGBP and RYGBP With Fundus Resection N/A
Not yet recruiting NCT03203161 - Registry on Obesity Surgery in Adolescents
Not yet recruiting NCT03601273 - Bariatric Embolization Trial for the Obese Nonsurgical Phase 1
Recruiting NCT02129296 - Intragastric Balloon, Air Versus Fluid Filled: Randomized Prospective Study Phase 1/Phase 2
Active, not recruiting NCT01564732 - Multicenter Prospective Randomized Controlled Trial of Plicated Laparoscopic Adjustable Gastric Banding N/A
Completed NCT02033265 - Ultrasound-Guided Axillary Brachial Plexus Block: Influence of Obesity
Not yet recruiting NCT01652105 - Randomized Trial of Preoperative Diets Before Bariatric Surgery N/A
Completed NCT01963637 - Gastric Volumetry by Gastric Tomodensitometry With Gas N/A
Terminated NCT01759550 - Prospective Case-Series of Ligasure Advance Pistol Grip and LigaSure Blunt Tip
Completed NCT01955993 - Fentanyl Metabolism in Obese Adolescents N/A
Completed NCT01149512 - Outcomes of the Adjustable Gastric Band in a Publicly Funded Obesity Program N/A
Recruiting NCT01685177 - Single Anastomosis Duodeno-Ileal Bypass vs Standard Duodenal Switch as a Second Step After Sleeve Gastrectomy in the Super-Morbid Obese Patient N/A
Completed NCT00624624 - Follow-up of Serum Androgen Profile After Bariatric Surgery in Men With Obesity Related Hypogonadotropic Hypogonadism N/A
Terminated NCT01041261 - Effects of a Novel Dietary Intervention on Body Composition After Laparoscopic Gastric Bypass Surgery N/A